WealthCollab’s United Therapeutics UTHR Stock Holding History

WealthCollab’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$61.2K	Sell	113 -4	-3%	-$2.25K	0.02%	208
2026 Q1	$69.4K	Sell	117 -6	-5%	-$2.99K	0.03%	170
2025 Q4	$59.9K	Buy	123 +6	+5%	+$2.79K	0.02%	206
2025 Q3	$49K	Buy	117 +11	+10%	+$3.7K	0.02%	199
2025 Q2	$30.5K	Buy	106 +38	+56%	+$11.4K	0.02%	252
2025 Q1	$21K	Sell	68 -7	-9%	-$2.4K	0.01%	310
2024 Q4	$26.5K	Hold	75	–	–	0.02%	258
2024 Q3	$26.9K	Buy	75 +3	+4%	+$1.01K	0.02%	261
2024 Q2	$22.9K	Buy	72 +4	+6%	+$1.06K	0.02%	263
2024 Q1	$15.6K	Buy	68 +47	+224%	+$10.6K	0.01%	338
2023 Q4	$4.62K	Buy	+21	New	+$4.84K	﹤0.01%	593

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

WealthCollab's UTHR Position: Q2 2026 in Review

WealthCollab reduced its United Therapeutics (UTHR) stake by 3.4% in Q2 2026, selling an estimated $2.25K and leaving 113 shares worth $61.2K. The position accounts for 0.02% of the portfolio, ranked #208.

WealthCollab first reported a position in UTHR in Q4 2023 and has held it in 11 quarters since. The position peaked at $69.4K in Q1 2026. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

WealthCollab held 113 shares of United Therapeutics worth $61.2K as of Q2 2026.
WealthCollab sold 4 United Therapeutics shares in Q2 2026, an estimated $2.25K.
United Therapeutics made up 0.02% of WealthCollab's portfolio in Q2 2026, its #208 holding.
WealthCollab first reported a position in United Therapeutics in Q4 2023 and has held it in 11 quarters since.
WealthCollab's United Therapeutics position peaked at $69.4K in Q1 2026.
882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.